Skip to main content
Top menu links
IMTM Portal
Support cancer research
User account menu
Log in
Language switcher
English
English
Czech
Home
About us
Mission & vision
Management
Administration
Science advisory board
IMTM board
Certificates
Media & PR
REACTOR conference
Technologies & services
Core facilities
Equipment
Clinical trials
Technologies
Research
Data access committee
Data management plan
Research programs
Research projects
Laboratories and Research groups
Publications
Product pipeline
Mendel-Zirm lectures
Careers
Why the IMTM?
Bachelor
Master
Doctoral
Vacancies
Information for foreigners
Contact
General contacts
Staff
How to find us
E-shop
Header image
Breadcrumb
Home
Design, Synthesis, and Biological Evaluation of Novel 3-oxo-2,3-dihydropyridazine Derivatives As Interleukin-2-inducible T-cell Kinase (ITK) Inhibitors
Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors
TANGALLAPALLI, S., R. GUNDLA, K. PAIDIKONDALA,
S. GURSKÁ
, N. RAMPEESA, S. ANUGU,
P. DŽUBÁK
,
M. HAJDÚCH
,
V. DAS
, N. KATARI
Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors. RSC advances. 2025, 15(55), 47565-47586, ISSN: 2046-2069, PMID:
41356712
,
PDF
.
